ProSense® — Regulatory decision
H2 2026
A decision is expected during the second half of 2026, subject to the agency's standard review procedures and potential follow-up questions.Source filing
ICCM biotech catalysts & pipeline
ICECURE MEDICAL LTD · Data as of 2026-09-08